Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 65.49M P/E - EPS this Y - Ern Qtrly Grth -
Income -8.03M Forward P/E -19.80 EPS next Y - 50D Avg Chg -
Sales 3.02M PEG - EPS past 5Y - 200D Avg Chg -62.00%
Dividend N/A Price/Book 31.18 EPS next 5Y - 52W High Chg -88.00%
Recommedations 3.00 Quick Ratio 0.05 Shares Outstanding 2.74M 52W Low Chg 61.00%
Insider Own 0.84% ROA -33.85% Shares Float 2.71M Beta 1.49
Inst Own 4.14% ROE - Shares Shorted/Prior 17.55K/11.03K Price 3.96
Gross Margin 35.96% Profit Margin -266.00% Avg. Volume 209,009 Target Price -
Oper. Margin -109.17% Earnings Date May 13 Volume 171,744 Change 7.03%
About INVO BioScience, Inc.

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

INVO BioScience, Inc. News
04/16/24 INVO Reports Fourth Quarter and Full Year 2023 Financial Results
01/23/24 NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
01/17/24 INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
12/11/23 NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal
12/06/23 NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
11/28/23 INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
11/13/23 INVO Reports Record Third Quarter 2023 Financial Results
11/13/23 BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger
11/10/23 NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
11/09/23 INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants
10/27/23 Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023
10/23/23 INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
10/11/23 INVO to Participate in the Lytham Partners Fall 2023 Investor Conference
09/29/23 INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS
09/28/23 INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET
08/14/23 INVO Reports Second Quarter 2023 Financial Results
08/11/23 INVO Closes Acquisition of Wisconsin Fertility Institute
08/09/23 INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
08/08/23 INVO Bioscience Announces Closing of $4.5 Million Public Offering
08/04/23 INVO Bioscience Announces Pricing of $4.5 Million Public Offering
INVO Chatroom

User Image GoGreen21 Posted - 3 hours ago

$INVO

User Image VIPTrades009 Posted - 3 hours ago

Next week watchlist: $MYSZ , $MICS , $ABVC , $INVO , $GNLN

User Image Vikings06 Posted - 4 hours ago

$INVO News about the merger with Naya before 30 April

User Image StockDeni Posted - 6 hours ago

$INVO BUY and HOLD Invo Bioscience reported $1.38 million in quarterly sales, representing a 396.15% increase over sales of $278,140 from the same period last year. Anyone that took the COVID Vaccine is now a customer. PROFITS are going to get higher. $BB WATCHING BUY and HOLD

User Image zachcole Posted - 6 hours ago

$INVO I thought this was going private. Omg I was so stressed

User Image stu_gats Posted - 9 hours ago

$INVO so.. is this the last hour of trading?

User Image perckel Posted - 16 hours ago

$INVO use mute button to avoid see mike*_*

User Image mikefbi Posted - 21 hours ago

$INVO Bruceleeboy Why would I be long when I was always bearish you would know that if you read my posting. Cheers

User Image bruceleeboy Posted - 22 hours ago

$INVO As usual, we agree to disagree. You don’t and have never owned INVO yet here you are.

User Image mikefbi Posted - 22 hours ago

$INVO You are delusional if you think that Immune Pharmaceuticals shares have value. Fact According to the United States Bankruptcy Code Chapter 7 and the United States Internal Revenue Service Immune Pharmaceuticals Inc. shares have no value. ( Write off) Cytovia Inc. filed for bankruptcy and is being liquidated Ceplene has already been sold. You are starting to appear to be not only delusional but a narcissist.

User Image bruceleeboy Posted - 22 hours ago

$INVO Mike, who owns Immune Pharma SAS? Why is Cytovia using Immune Pharma’s research? Why did Cytovia create Naya to spin off some of that research and then acquire Invo? Thoughts Mike? Does a parrot even have thoughts? 🤔

User Image bruceleeboy Posted - 22 hours ago

$INVO Yes Mike. I think Immune Pharmaceuticals has value. Cytovia has value and Invo’s fertility tech have value. All companies have Mr. Teper to thank for their situation and ultimate consolidation.

User Image mikefbi Posted - 23 hours ago

$INVO Bruceleeboy You are delusional. I have been negative since the merger announcement and the failure of Naya Biosciences to make payments as per the merger agreement. As stated in my posting I believe that this was a pump-and-dump scenario Like Cytovia was going to spin off from Immune Pharmaceuticals' nice pump and then dump. In case you forgot I sold all my shares except for 1000 shares while you kept pumping the stock & you still believe that Immune Pharmaceuticals will have value hilarious. Spinoff never happened My track record speaks for itself

User Image mikefbi Posted - 1 day ago

$INVO Bruceleeboy You still think Immune Pharmaceuticals shares have value contrary to undisputed evidence that no company that has been liquidated under Chapter 7 shares ever traded again.

User Image bruceleeboy Posted - 1 day ago

$INVO Wake up Mike. LK called INVO delisting roughly 4 months ago. You conveniently left that factoid out. Mikes haunting this board also because he’s a tool. I think of him as my red headed step child. He’s harmless aside from being aggressively insipid and refusing to acknowledge the truth and details of these deals. We’re close.

User Image bruceleeboy Posted - 1 day ago

$INVO Intentionally revoked Mike. Same as Teper once again has decided to take no action with Invo. They wanted it delisted then. They want this delisted now.

User Image mikefbi Posted - 1 day ago

$INVO Bruceleeboy You left out Immune Pharmaceuticals shares revoked by the Securities Exchange Commission.

User Image mikefbi Posted - 1 day ago

$INVO Bruceleeboy statement is false Isleworth Healthcare Dissolved. Immune Pharmaceuticals filed for Chapter 11 and Dr. Teper and or company were going to purchase Ceplene for millions but failed to purchase said asset the court converted to Chapter 7 bankruptcy. Ceplene was later sold for under 200 thousand dollars Shareholders value now .000000 If the merger fails and INVO can't raise additional capital they might seek bankruptcy protection and the winner again will be Dr.Teper and the Shareholders could be wiped out. Here are the risk factors for Invo :

User Image bruceleeboy Posted - 1 day ago

$INVO Hold your shares. They’ll be better off with future transactions - SPAC’s, mergers, reverse mergers. INVO is a piece in a much larger acquisition strategy. Do your DD into Cytovia, Naya’s parent. Do your DD into Daniel Teper and his previous exploits with Immune Pharmaceuticals. Isn’t the first time he’s had a delisting on his watch or even his second. This was intentional same as Isleworth Healthcare Acquisition. They merged and delisted. Immune had a acquisition and subsequently delisted. Invo is simply the next stop on the train. It’s the CE Hoe’s signature move like a video game. His finisher is delisting 🫠His finger print if you will. Voluntarily vs. forced vs. no action taken. INVO is already a part of Naya. It’s their fertility arm. Deals technically done. But remember, all of this sort of business isn’t over.

User Image stu_gats Posted - 1 day ago

$INVO

User Image TheGenieOfWallstreet Posted - 1 day ago

$ICU Something I can tell ya’ll for certain now, Kevin Chung cares about his share holders. I 💙 the stock. $ABVC $INVO $BTAI $HOLO

User Image Celz Posted - 1 day ago

$INVO 0,3 coming

User Image Lukeinthesky Posted - 1 day ago

$INVO 80 CENTS coming. Ready to buy 🤗

User Image driv300mph Posted - 1 day ago

$INVO Sold last night as soon as I saw the service for their investors page had expired. Pretty bad sign

User Image stu_gats Posted - 1 day ago

$INVO

User Image mikefbi Posted - 1 day ago

$INVO Wondering if Dr. Teper of Naya Biosciences wants INVO to be delisted so he can back out of the deal?

User Image pennymagician1759 Posted - 1 day ago

$INVO I’m not selling

User Image redog677 Posted - 1 day ago

company not putting out any news so we shareholders really have no choice unless youre gonna play russian roulette.$INVO

User Image redog677 Posted - 1 day ago

$INVO well I just sold as well, so it probably will jump up now.

User Image stu_gats Posted - 1 day ago

$INVO i've just sold so it probably going to skyrocketing from now on

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Shum Steve Chief Executive Offi.. Chief Executive Officer Jun 01 Buy 0.95 58,885 55,941 128,420 06/03/22
Szot Matthew K Director Director Jun 01 Buy 0.95 14,474 13,750 39,175 06/03/22
Ryan Barbara Director Director Jun 01 Buy 0.95 10,526 10,000 22,991 06/03/22
DAVIS TRENT D Director Director Jun 01 Buy 0.95 11,184 10,625 33,622 06/03/22
Segal Jeffrey Director Director Jun 01 Buy 0.95 9,211 8,750 28,220 06/03/22
Campbell Michael Jos. Chief Operating Offi.. Chief Operating Officer Jun 01 Buy 0.95 10,526 10,000 75,762 06/03/22
Goren Andrea Chief Financial Offi.. Chief Financial Officer Jun 01 Buy 0.95 52,632 50,000 129,015 06/03/22
Messina Rebecca Director Director Jun 01 Buy 0.95 9,868 9,375 23,045 06/03/22
Doody Kevin Medical Director Medical Director Jun 01 Buy 0.95 177,306 168,441 06/03/22